Show simple item record

dc.contributor.advisorJamin, Y
dc.contributor.authorZormpas Petridis, K
dc.date.accessioned2021-08-25T09:46:55Z
dc.date.available2021-08-25T09:46:55Z
dc.date.issued2021-01-31
dc.identifier.citation2021
dc.identifier.urihttps://repository.icr.ac.uk/handle/internal/4774
dc.description.abstractNeuroblastoma is a common childhood solid tumour that accounts for 15% of all cancer paediatric deaths. This thesis addresses key deficiencies in our ability to define, monitor and predict neuroblastoma heterogeneity for precision medicine. I used computational science to integrate the spatially-encoded phenotypic information provided by multi-parametric magnetic resonance imaging (MRI) with digital histopathology, demonstrating that MRI can provide non-invasive pathology to characterise neuroblastoma heterogeneity and provide biomarkers of response in clinically-relevant transgenic mouse models of high-risk disease. I first developed and demonstrated the application of novel computational pathology methodologies to enhance the quantitative assessment of tumour components from H&E-stained whole-slide images (WSI). These include two frameworks: SuperCRF, which fuses traditional machine learning with deep learning to model the way pathologists incorporate large-scale tissue architecture and context across spatial spaces to significantly improve single-cell classification and, SuperHistopath, which combines the application of the SLIC superpixels algorithm on low-magnification WSIs (5x) with a convolutional neural network (CNN) for superpixels classification to accurately map tumour heterogeneity from low-resolution histology. I then developed an MRI-histopathology cross-validation pipeline which provides the rigorous validation needed to support the deployment of novel MRI scans in the neuroblastoma clinic. Using this platform, I demonstrated the sensitivity of susceptibility-, T1-Mapping- and diffusion-weighted-MRI to the cellular and microenvironmental hallmarks of high-risk neuroblastoma and their modulation by either vascular- or MYCN-targeted therapies. Finally, I used supervised machine learning classification- and regression-based approaches to show proof-of-concept that habitat imaging derived from these three scans can non-invasively provide quantitative data typically acquired from histological analysis, such as densities of specific cell populations. This thesis demonstrates the potential of multi-parametric MRI to deliver non-invasive "virtual" biopsies to enhance diagnostic and treatment monitoring for children with neuroblastoma and pave new ways in studying tumour as an evolving ecosystem.
dc.languageeng
dc.language.isoeng
dc.publisherInstitute of Cancer Research (University Of London)
dc.rights.urihttps://www.rioxx.net/licenses/all-rights-reserved
dc.subjectTheses, Doctoral
dc.subjectNeuroblastoma - Radiology
dc.subjectComputational Medicine
dc.subjectMagnetic Resonance Imaging
dc.subjectComputational Pathology
dc.subjectComputational Science
dc.subjectMachine Learning
dc.subjectHistopathology
dc.titleComputational science-enabled radiological pathology for the non-invasive mapping of tumour heterogeneity in childhood neuroblastoma
dc.typeThesis or Dissertation
dcterms.accessRightsPublic
dcterms.licensehttps://www.rioxx.net/licenses/all-rights-reserved
rioxxterms.versionAO
rioxxterms.licenseref.urihttps://www.rioxx.net/licenses/all-rights-reserved
rioxxterms.licenseref.startdate2021-01-31
rioxxterms.typeThesis
pubs.notesNo embargo
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging/Computational Imaging
pubs.organisational-group/ICR/Students
pubs.organisational-group/ICR/Students/PhD and MPhil
pubs.organisational-group/ICR/Students/PhD and MPhil/16/17 Starting Cohort
pubs.embargo.termsNo embargo
icr.researchteamComputational Imagingen_US
dc.contributor.icrauthorZormpas Petridis, Konstantinos
uketdterms.institutionInstitute of Cancer Research
uketdterms.qualificationlevelDoctoral
uketdterms.qualificationnamePh.D
dc.type.qualificationlevelDoctoral
dc.type.qualificationnamePh.D


Files in this item

Thumbnail

This item appears in the following collection(s)

Show simple item record